An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue

1994 Brown, 1993, Neonatal consequences of preterm birth, 465 Escobedo, 1988, Follow-up of prematurely born infants, Clin Obstet Gynecol, 31, 662, 10.1097/00003081-198809000-00012 Arias, 1982, Etiology and outcome of low birth weight and preterm infants, Obstet Gynecol, 60, 277 King, 1988, Betamimetics in preterm labour: an overview of the randomized controlled trials, Br J Obstet Gynaecol, 95, 211, 10.1111/j.1471-0528.1988.tb06860.x The Canadian Preterm Labor Investigators Group, 1992, Treatment of preterm labor with the beta-adrenergic agonist ritodrine, N Engl J Med, 327, 308, 10.1056/NEJM199207303270503 Merkatz, 1980, Ritodrine hydrochloride: a beta-mimetic agent for use in preterm labor. II. Evidence of efficacy, Obstet Gynecol, 56, 712 Hudgens, 1993, Sudden death associated with terbutaline sulfate administration, Am J Obstet Gynecol, 169, 120, 10.1016/0002-9378(93)90144-8 Katz, 1981, Cardiovascular complications associated with terbutaline treatment for preterm labor, Am J Obstet Gynecol, 139, 605, 10.1016/0002-9378(81)90524-X Foley, 1993, Effect of prolonged oral terbutaline therapy on glucose tolerance in pregnancy, Am J Obstet Gynecol, 168, 100, 10.1016/S0002-9378(12)90894-7 Macones, 1995, Efficacy of oral beta-agonist maintenance therapy in preterm labor: a meta-analysis, Obstet Gynecol, 85, 313, 10.1016/0029-7844(94)00374-M Besinger, 1991, Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor, Am J Obstet Gynecol, 164, 981, 10.1016/0002-9378(91)90569-D Molnar, 1990, Regulation of intracellular free calcium in human myometrial cells by prostaglandin F2 alpha: comparison with oxytocin, J Clin Endocrinol Metab, 71, 1243, 10.1210/jcem-71-5-1243 Norton, 1993, Neonatal complications after the administration of indomethacin for preterm labor, N Engl J Med, 329, 1602, 10.1056/NEJM199311253292202 Zingg, 1993, Uterine oxytocin gene expression: a novel framework for oxytocin action, Regul Pept, 45, 43, 10.1016/0167-0115(93)90180-G Fuchs, 1991, Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women, Am J Obstet Gynecol, 165, 1515, 10.1016/S0002-9378(12)90793-0 Fuchs, 1984, Oxytocin receptors in the human uterus during pregnancy and parturition, Am J Obstet Gynecol, 150, 734, 10.1016/0002-9378(84)90677-X Soloff, 1985, Oxytocin receptors and the onset of parturition, 289 Akerlund, 1987, Inhibition of uterine contractions of premature labour with an oxytocin analogue: results from a pilot study, Br J Obstet Gynaecol, 94, 1040, 10.1111/j.1471-0528.1987.tb02287.x Giussani, 1996, The oxytocin antagonist atosiban prevents androstenedione-induced myometrial contractions in the chronically instrumented, pregnant rhesus monkey, Endocrinology, 137, 3302, 10.1210/endo.137.8.8754755 Goodwin, 1994, The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human, Am J Obstet Gynecol, 170, 474, 10.1016/S0002-9378(94)70214-4 Goodwin, 1995, The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions, Am J Obstet Gynecol, 173, 913, 10.1016/0002-9378(95)90365-8 Goodwin, 1996, Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor, Obstet Gynecol, 88, 331, 10.1016/0029-7844(96)00200-1 Phaneuf, 1994, Effect of oxytocin antagonists on the activation of human myometrium in vitro: atosiban prevents oxytocin-induced desensitization, Am J Obstet Gynecol, 171, 1627, 10.1016/0002-9378(94)90414-6 Schoenfeld, 1981, The asymptotic properties of nonparametric tests for comparing survival distributions, Biometrika, 68, 316, 10.1093/biomet/68.1.316 Gillings, 1991, The application of the principle of intention-to-treat to the analysis of clinicial trials, Drug Inform J, 25, 411, 10.1177/009286159102500311 Lee, 1992, Statistical methods for survival data analysis, 1 WHOART version 1992, third quarter. WHO, The Uppsala Monitoring Center, WHO Collaborating Centre for International Drug Monitoring, Stora Torget 3, S-753 20 Uppsala, Sweden. Goldenberg, 1998, Prevention of premature birth, N Engl J Med, 339, 313, 10.1056/NEJM199807303390506 Keirse, 1989, Preterm labour, 194 Romero, 1994, The pretem labor syndrome, Ann N Y Acad Sci, 734, 414, 10.1111/j.1749-6632.1994.tb21771.x Romero, 1989, Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes, Am J Obstet Gynecol, 161, 817, 10.1016/0002-9378(89)90409-2 Gomez, 1998, The fetal inflammatory response syndrome, Am J Obstet Gynecol, 179, 194, 10.1016/S0002-9378(98)70272-8 Gore, 1989, Perinatal fluid and electrolyte regulation: role of arginine vasopressin, Semin Perinatol, 12, 134 1998, Advisory Committee for Reproductive Health Drugs, 198 Advisory Committee for Reproductive Health Drugs, 1998 1998, Advisory Committee for Reproductive Health Drugs, 24 Creasy, 1993, Basic research and clinical experiences with β-adrenergic tocolytics in the United States, 243 Moutquin, 2000, Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study, Am J Obstet Gynecol, 182, 1191, 10.1067/mob.2000.104950 1998, Advisory Committee for Reproductive Health Drugs, 60 Shankaran, 1997, The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants, N Engl J Med, 337, 466, 10.1056/NEJM199708143370705 Mittendorf, 1997, Is tocolytic magnesium sulphate associated with increased total paediatric mortality?, Lancet, 350, 1517, 10.1016/S0140-6736(97)24047-X Mittendorf, 1998, If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact?, Obstet Gynecol, 92, 308, 10.1016/S0029-7844(98)00163-X The Eclampsia Trial Collaborative Group, 1995, Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial, Lancet, 345, 1455, 10.1016/S0140-6736(95)91034-4